Page last updated: 2024-08-24

pyrrolidine dithiocarbamate and Inflammatory Response Syndrome, Systemic

pyrrolidine dithiocarbamate has been researched along with Inflammatory Response Syndrome, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boyle, EM; Canty, TG; Caps, MT; Farr, AL; Frank, N; Kovacich, JC; Morgan, EN; Pohlman, TH; Verrier, ED	1

Other Studies

1 other study(ies) available for pyrrolidine dithiocarbamate and Inflammatory Response Syndrome, Systemic

Article	Year
Inhibition of the transcriptional activator protein nuclear factor kappaB prevents hemodynamic instability associated with the whole-body inflammatory response syndrome. The Journal of thoracic and cardiovascular surgery, 1999, Volume: 118, Issue:1 Topics: Acidosis; Animals; Antioxidants; Disease Models, Animal; Drug Evaluation, Preclinical; Hemodynamics; Hypotension; Infusions, Intravenous; Interleukin-1; NF-kappa B; Proline; Pyrrolidines; Rabbits; Random Allocation; Systemic Inflammatory Response Syndrome; Thiocarbamates	1999

Article

Year

Inhibition of the transcriptional activator protein nuclear factor kappaB prevents hemodynamic instability associated with the whole-body inflammatory response syndrome.

The Journal of thoracic and cardiovascular surgery, 1999, Volume: 118, Issue:1

Topics: Acidosis; Animals; Antioxidants; Disease Models, Animal; Drug Evaluation, Preclinical; Hemodynamics; Hypotension; Infusions, Intravenous; Interleukin-1; NF-kappa B; Proline; Pyrrolidines; Rabbits; Random Allocation; Systemic Inflammatory Response Syndrome; Thiocarbamates

1999